Livdelzi® (seladelpar)
| Full Name | Livdelzi® (seladelpar) |
| Drug | Livdelzi |
| Manufacturer | Gilead Sciences, Inc. |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA |
| Disease | Primary Biliary Cholangitis (PBC) |
| Therapeutic Area | Hepatology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 888-263-8004 |
| Fax Number | 877-846-0402 |
| Product Website | livdelzihcp.com/ |
| Patient Resources | • PBCers Organization • Orsini/PBCers 2025 Webinar – “Specialty Pharmacy: Partners in Your Care” | Watch On-Demand → |